Insitro
UnclaimedLeveraging machine learning and data to accelerate drug discovery and development.
Visit WebsiteTL;DR - Insitro
- Uses machine learning and data to accelerate drug discovery.
- Integrates cellular and human clinical data for therapeutic insights.
- Developing a pipeline in metabolism, oncology, and neuroscience.
Pricing: Paid only
Best for: Enterprises & pros
Pricing
Paid
Insitro offers paid plans. Visit their website for current pricing details.
About Insitro
Insitro is a drug discovery and development company that uses machine learning (ML) and large-scale data to redefine how new medicines are created. The company integrates in vitro cellular data from its labs with human clinical data to build a robust ML-driven platform. This platform is designed to decode biological complexities, identify therapeutic insights, and accelerate the development of new drugs across various diseases.
Insitro's approach aims to bring better drugs to patients faster by precisely identifying interventions. They are building a pipeline of wholly-owned and partnered therapeutic programs focusing on metabolism, oncology, and neuroscience. The company fosters a unique culture where diverse experts, including life scientists, data scientists, engineers, and drug hunters, collaborate to drive scientific breakthroughs in drug discovery.
Reviews
No reviews yet. Be the first to review Insitro!
Write a ReviewExplore More
Insitro FAQ
Insitro is a drug discovery and development company that utilizes machine learning and large-scale data to identify therapeutic insights and accelerate the creation of new medicines. They integrate in vitro cellular data with human clinical data to build a platform for drug development.
Insitro is a drug discovery company, not a software product with a direct pricing model for external users. Its services and products are likely part of partnerships or internal development, and therefore, no public pricing information is available.
No, Insitro is a drug discovery company and does not offer free services or products to the general public. Its operations involve significant research and development investments.
Insitro is for patients who can benefit from new medicines, and for pharmaceutical partners interested in leveraging machine learning for drug discovery. Internally, it's for life scientists, data scientists, engineers, and drug hunters who collaborate on its platform.